249 Artículos relativos a Medicamentos Genéricos

• The drug wars.
  Publicado en N Engl J Med
• Can quality be preserved when generics are used?.
  Publicado en QA Rev
• Synonympraeparatmarkedet i Danmark 1985-1990. En sammenligning af prisniveauer og markedsandele.
  Publicado en Ugeskr Laeger
• Generic drug companies are the winners.
  Publicado en CMAJ
• Liability relating to formularies and drug utilization management.
  Publicado en AAPPO J
• Drug product selection--Part 3: The Orange Book.
  Publicado en Am Pharm
• Topical corticosteroids.
  Publicado en Med Lett Drugs Ther
• Pharmacists have more responsibilities, liabilities than hospital materials managers. Part 1.
  Publicado en Hosp Mater Manage
• Economic prescribing.
  Publicado en Drug Ther Bull
• Adverse reaction to generic alprazolam.
  Publicado en Am J Psychiatry
• How a longstanding P & T Committee identifies and meets current therapeutic challenges.
  Publicado en Hosp Formul
• Evaluation of generic-brand name knowledge.
  Publicado en DICP
• Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
  Publicado en Clin Ther
• Special report: the value of pharmaceuticals. Data watch. Managed care and prescription drugs.
  Publicado en Bus Health
• Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism.
  Publicado en Biometrics
• Generic prescribing of antidepressants.
  Publicado en J R Soc Med
• Referensprissystemet på läkemedel sparar 5 miljarder kr om året i Tyskland.
  Publicado en Lakartidningen
• Synonympraeparatet Andion versus originalpraeparatet Becotide til behandling af steroidafhaengig asthma bronchiale. En sammenlignende dobbeltblind overkrydsningsundersogelse.
  Publicado en Ugeskr Laeger
• Generisk substitution--patientens incitament for lille.
  Publicado en Ugeskr Laeger
• Relative bio-availability of sultamicillin in healthy volunteers following administration of two tablet formulations.
  Publicado en J Int Med Res
• Regulatory requirements for generic chiral drugs.
  Publicado en J Clin Pharmacol
• Taking the "cef" out of cephalosporins.
  Publicado en Nurse Pract
• Prudent prescribing. Prescribing suggestions for physicians.
  Publicado en N C Med J
• Generic substitution--another form of alternative medicine.
  Publicado en J R Coll Physicians Lond
• Drug nomenclature: suggestions for change.
  Publicado en CMAJ
• Drug nomenclature suggestions for change.
  Publicado en CMAJ
• Developing a pharmaceutical purchasing strategy.
  Publicado en Hosp Formul
• Understanding compound drugs.
  Publicado en Nurs Times
• Original versus generic piroxicams, their cost-effective evaluation in rheumatoid arthritis (RA) patients.
  Publicado en J Med Assoc Thai
• Attempt to sell generic version of zidovudine angers brand name company, researchers.
  Publicado en CMAJ
• Employers push to manage prescription drug costs.
  Publicado en Bus Health
• The emerging effects of the Drug Price Competition and Patent Term Restoration Act of 1984.
  Publicado en J Contemp Health Law Policy
• The effect of consumer perceptions on generic OTC usage among the elderly.
  Publicado en Health Mark Q
• Patient medication costs as a therapeutic consideration.
  Publicado en J Am Dent Assoc
• The 'little, round, white pill' problem.
  Publicado en Am Pharm
• Elderly patients and their medication: a post-discharge follow-up study.
  Publicado en Age Ageing
• Loss of seizure control associated with generic substitution of carbamazepine.
  Publicado en Ann Pharmacother
• Guidelines to consider when buying generic drugs for worksite dispensing. United States Food and Drug Administration.
  Publicado en Occup Health Saf
• Therapeutic bioequivalency study of brand name versus generic carbamazepine.
  Publicado en Neurology
• Bioequivalence studies: single vs multiple dose.
  Publicado en Int J Clin Pharmacol Ther Toxicol
• ASHP guidelines on formulary system management.
  Publicado en Am J Hosp Pharm
• Generic versus brand name drug prescribing by resident physicians in Pennsylvania.
  Publicado en Am J Hosp Pharm
• Drug information service for drug product procurement in the Veterans Affairs health-care system: preliminary experience.
  Publicado en Am J Hosp Pharm
• Types of bioequivalence and related statistical considerations.
  Publicado en Int J Clin Pharmacol Ther Toxicol
• DPS--the PMA perspective.
  Publicado en Am Pharm
• Projecting future drug expenditures--1992.
  Publicado en Am J Hosp Pharm
• Is Rx couponing a viable direct-marketing technique?.
  Publicado en Am Pharm
• The decline in new drug development.
  Publicado en Am Pharm
• Cute sayings, costly drugs.
  Publicado en JAMA
• Brand name drug companies appear to hold winning hand in GATT talks.
  Publicado en CMAJ
• Reassurance about bioequivalence of generic thyroxine.
  Publicado en N Z Med J
• Generic drug prices still falling.
  Publicado en Hosp Mater Manage
• Look-alike and sound-alike drug names: the problem and the solution.
  Publicado en Hosp Pharm
• Abuse of brand names in era of essential drugs.
  Publicado en Lancet
• Prescription cost sharing: economic and health impacts, and implications for health policy.
  Publicado en Pharmacoeconomics
• Pitfalls in the interpretation of pharmacoeconomic studies.
  Publicado en Pharmacoeconomics
• Perspectives. Drug utilization review: apocalypse when?.
  Publicado en Faulkner Grays Med Health
• Interchangeability of oral contraceptive products.
  Publicado en CMAJ
• Generic drugs with special attention to antibiotics.
  Publicado en Int J Dermatol
• Drug selection and information: some recommendations from the World Health Organization.
  Publicado en J R Coll Physicians Lond
• Ordningen med billigste synonympreparat--virker den etter hensikten?.
  Publicado en Tidsskr Nor Laegeforen
• Fremskrittets pris.
  Publicado en Tidsskr Nor Laegeforen
• Antibiotic policies.
  Publicado en Practitioner
• Carbamazepine toxicity resulting from generic substitution.
  Publicado en Neurology
• Bioequivalency revisited: epitol versus tegretol.
  Publicado en Neurology
• Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs.
  Publicado en BMJ
• The generic drug approval process.
  Publicado en Am Fam Physician
• Mail-order sales of drugs without prescriptions under investigation by US, Canadian agencies.
  Publicado en CMAJ
• Ska vi acceptera dåliga kopior?.
  Publicado en Lakartidningen
• Branded generics.
  Publicado en J Clin Pharmacol
• Points to consider about prescription drug prices: an overview of federal policy and pricing studies.
  Publicado en Clin Ther
• Standards of aerosol therapy.
  Publicado en CMAJ
• A possible hazard in labeling of generic products.
  Publicado en Postgrad Med
• The way to economic prescribing.
  Publicado en Health Policy
• Health care reform: pharmaceutical industry sees itself as 'whipping boy'.
  Publicado en Hosp Formul
• Drug names and medication errors: who is responsible?.
  Publicado en CMAJ
• Illegibility of drug ampoule labels.
  Publicado en BMJ
• Prescription labeling.
  Publicado en Am Fam Physician
• 'Shake-up' in drug industry predicted. Interview by Bob Carlson.
  Publicado en Indiana Med
• Differences in serum concentrations of and responses to generic verapamil in the elderly.
  Publicado en Pharmacotherapy
• Bioequivalence of metered-dose inhaled medications.
  Publicado en J Allergy Clin Immunol
• Future pharmacists and public initiatives to control retail drug prices: a political economy framework.
  Publicado en Health Mark Q
• Essential drugs should be accessible to all people.
  Publicado en World Health Forum
• Dispensing in general practice. Legal pitfalls with generic prescribing.
  Publicado en BMJ
• Pill bottle confusion: dual labels would help.
  Publicado en Geriatrics
• Quantitative vasoconstrictor assay for topical corticosteroids: the puzzling case of fluocinolone acetonide.
  Publicado en J Am Acad Dermatol
• Western medications needed in Lithuania.
  Publicado en Am J Psychiatry
• Parallelimporterede praeparater. En undersogelse af prisudviklingen for parallelimporterede proeparater versus originalproeparaterne.
  Publicado en Ugeskr Laeger
• Limiting the drugs list. The trouble with generic prescribing.
  Publicado en BMJ
• The effects of copayments and generic substitution on the use and costs of prescription drugs.
  Publicado en Inquiry
• A proposal for using generics.
  Publicado en Pa Med
• Bioequivalence/bioavailability retention samples.
  Publicado en Qual Assur
• Generic prescribing of antidepressants.
  Publicado en J R Soc Med
• Prescribing costs in dispensing practices.
  Publicado en BMJ
• Multisource drugs: implications and concerns in the geriatric population.
  Publicado en Hosp Pharm
• Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals.
  Publicado en Hosp Pharm
• Generic and alternative brand-name pharmaceutical equivalents: select with caution.
  Publicado en Am J Hosp Pharm
• Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
  Publicado en Am J Hosp Pharm
• Program for reimbursement of cognitive services is misleading.
  Publicado en Am J Hosp Pharm
• Why drug prices will go lower.
  Publicado en Fortune